RhumbLine Advisers’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $547K | Sell |
|
|||||
|
2025
Q2 | $568K | Buy |
|
|||||
|
2025
Q1 | $446K | Buy |
|
|||||
|
2024
Q4 | $648K | Sell |
|
|||||
|
2024
Q3 | $736K | Sell |
|
|||||
|
2024
Q2 | $721K | Buy |
|
|||||
|
2024
Q1 | $29.1K | Buy |
|
|||||
|
2023
Q4 | $6.39K | Hold |
|
|||||
|
2023
Q3 | $8.38K | Hold |
|
|||||
|
2023
Q2 | $5.58K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $345K | Sell |
|
|||||
|
2021
Q4 | $409K | Sell |
|
|||||
|
2021
Q3 | $695K | Buy |
|
|||||
|
2021
Q2 | $635K | Sell |
|
|||||
|
2021
Q1 | $512K | Sell |
|
|||||
|
2020
Q4 | $705K | Buy |
|
|||||
|
2020
Q3 | $761K | Sell |
|
|||||
|
2020
Q2 | $476K | Buy |
|
|||||
|
2020
Q1 | $211K | Sell |
|
|||||
|
2019
Q4 | $292K | Sell |
|
|||||
|
2019
Q3 | $389K | Sell |
|
|||||
|
2019
Q2 | $1.04M | Buy |
|
|||||
|
2019
Q1 | $539K | Buy |
|
|||||
|
2018
Q4 | $297K | Buy |
|
|||||
|
2018
Q3 | $181K | Sell |
|
|||||
|
2018
Q2 | $154K | Sell |
|
|||||
|
2018
Q1 | $195K | Buy |
|
|||||
|
2017
Q4 | $165K | Sell |
|
|||||
|
2017
Q3 | $157K | Buy |
|
|||||
|
2017
Q2 | $123K | Sell |
|
|||||
|
2017
Q1 | $183K | Buy |
|
|||||
|
2016
Q4 | $225K | Sell |
|
|||||
|
2016
Q3 | $268K | Buy |
|
|||||
|
2016
Q2 | $298K | Buy |
|
|||||
|
2016
Q1 | $224K | Buy |
|
|||||
|
2015
Q4 | $298K | Buy |
|
|||||
|
2015
Q3 | $207K | Buy |
|
|||||
|
2015
Q2 | $596K | Sell |
|
|||||
|
2015
Q1 | $1.1M | Buy |
|
|||||
|
2014
Q4 | $740K | Sell |
|
|||||
|
2014
Q3 | $550K | Sell |
|
|||||
|
2014
Q2 | $663K | Buy |
|
|||||
|
2014
Q1 | $926K | Sell |
|
|||||
|
2013
Q4 | $868K | Buy |
|
|||||
|
2013
Q3 | $494K | Sell |
|
|||||
|
2013
Q2 | $397K | Buy |
|